matthew kulke, md | fda approves carcinoid syndrome drug
Published 7 years ago • 2.9K plays • Length 2:09
Download video MP4
Download video MP3
Similar videos
-
0:55
dr. matthew h. kulke talks about telotristat etiprate benefitting carcinoid syndrome patients
-
1:00:52
luncheon with the experts: matthew h. kulke, md
-
59:09
luncheon with the experts: matthew h. kulke, md
-
54:04
yale cancer center grand rounds: matthew kulke, md
-
1:13
why pfs is a good outcome measure for neuroendocrine tumors
-
1:21
dr. kulke on emerging cabozantinib data for nets
-
1:50
thomas abrams, md, medical oncologist, dana-farber cancer institute
-
1:00:19
luncheon with the experts: satya (nanu) das, md, msci
-
7:12
rare disease day special 2017: understanding neuroendocrine tumors
-
3:46
will ai cure cancer?
-
2:29
treatments on the horizon in nets
-
0:57
net cancer day matters with matt kulke hd 720p
-
3:05
douglas rubinson, md, phd, medical oncologist, dana-farber
-
1:34
anuj patel, md, medical oncologist, dana-farber cancer institute
-
5:15
deborah schrag, md, mph, dana-farber cancer institute
-
1:15
asco22: chris manz, md on ai in oncology | dana-farber cancer institute
-
8:09
pancreas and biliary tumor center video – dana-farber/brigham and women’s cancer center
-
1:54
ross s. berkowitz, md, on gynecologic cancer treatment | dana-farber cancer institute
-
1:51
kerry kilbridge, md, msc, dana-farber cancer institute, medical oncology
-
2:43
thomas e. clancy, md, facs, co-director dfci pancreas and biliary tumor center
-
1:01:07
luncheon with the experts: philip a philip, md, phd
-
2:26
dr. mark kieran talks about pediatric brain tumors at asco 2012 | dana-farber cancer institute
Clip.africa.com - Privacy-policy